Longitudinal Corneal Endothelial Cell Changes in Patients Undergoing Hematopoietic Stem Cell Transplantation

被引:7
作者
Pellegrini, Marco [1 ,2 ]
Giannaccare, Giuseppe [3 ]
Bernabei, Federico [1 ,2 ]
Moscardelli, Fabiana [1 ,2 ]
Sessa, Mariarosaria [2 ,4 ]
Arpinati, Mario [2 ,4 ]
Bonifazi, Francesca [1 ,2 ]
Versura, Piera [1 ,2 ]
机构
[1] Univ Bologna, Alma Mater Studiorum, Ophthalmol Unit, DIMES, Bologna, Italy
[2] S Orsola Malpighi Teaching Hosp, Bologna, Italy
[3] Magna Graecia Univ Catanzaro, Dept Ophthalmol, Catanzaro, Italy
[4] Univ Bologna, Hematol Unit, DIMES, Alma Mater Studiorum, Bologna, Italy
关键词
hematopoietic stem cell transplantation; ocular graft versus host disease; corneal endothelium; GVHD; dry eye; VERSUS-HOST-DISEASE;
D O I
10.1097/ICO.0000000000002441
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate longitudinally corneal endothelial cell changes in patients undergoing hematopoietic stem cell transplantation (HSCT) and to further investigate possible correlations with hematological and ocular characteristics. Methods: Prospective observational study conducted at a single center. All patients underwent a comprehensive ophthalmological examination, before and after HSCT, including slitlamp examination, Schirmer test, tear breakup time, ocular surface staining, specular microscopy of corneal endothelium, and Ocular Surface Disease Index questionnaire. Results: Twenty-five patients undergoing HSCT and 25 age- and sex-matched controls were included. At baseline, hematological patients showed significantly lower values of endothelial cell density (ECD) compared with those of controls (2514.5 +/- 390.2 vs. 2723.7 +/- 298.0 cells/mm(2), P = 0.038). After HSCT, ocular surface disease index score significantly increased (P = 0.020) and tear breakup time significantly decreased (P = 0.036). Conversely, no significant changes were found in Schirmer test and corneal fluorescein staining (always P > 0.05). Eight patients (32%) developed ocular graft-versus-host disease (GVHD). ECD values significantly decreased after HSCT (from 2514.5 +/- 390.2 to 2409.5 +/- 330.9 cells/mm(2), P = 0.009). The decrease in ECD values after HSCT was more pronounced in patients with ocular GVHD compared with those without (231.1 +/- 188.8 vs. 45.6 +/- 156.5, P = 0.016). No significant correlations between the changes in ECD and hematological and ocular characteristics were found (always P > 0.05). Conclusions: Hematological patients showed a lower endothelial cell count already before HSCT, compared with controls. After HSCT, the endothelial cell count further significantly decreased, particularly in patients who developed ocular GVHD.
引用
收藏
页码:462 / 466
页数:5
相关论文
共 50 条
  • [21] Psychological and cytokine changes in children and adolescents undergoing hematopoietic stem cell transplantation
    Munitz-Shenkar, Dafna
    Krulik, Tamar
    Peretz, Chava
    Shiloh, Roni
    Elhasid, Ronit
    Toren, Amos
    Weizman, Abraham
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (01) : 58 - 63
  • [22] Ocular manifestations and quality of life in patients after hematopoietic stem cell transplantation
    Fan, Shu-Xian
    Wang, Wen-Hui
    Zeng, Peng
    Huang, Ke-Zhi
    Hu, Yu-Xin
    Wang, Jing
    Li, Yi-Qing
    Xiao, Jian-Hui
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2023, 16 (07) : 1138 - 1144
  • [23] Hematopoietic Stem Cell Transplantation: History and Perioperative Care of Patients Undergoing HSCT
    David S. Beebe
    Kumar G. Belani
    Current Anesthesiology Reports, 2018, 8 (2) : 197 - 201
  • [24] Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation
    Wiskemann, J.
    Huber, G.
    BONE MARROW TRANSPLANTATION, 2008, 41 (04) : 321 - 329
  • [25] Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation
    Nakamura, Zev M.
    Deal, Allison M.
    Rosenstein, Donald L.
    Quillen, Laura J.
    Chien, Stephanie A.
    Wood, William A.
    Shea, Thomas C.
    Park, Eliza M.
    SUPPORTIVE CARE IN CANCER, 2021, 29 (04) : 2007 - 2014
  • [26] Survival protection of patients undergoing hematopoietic stem cell transplantation: grounded theory
    Mohamadifard, Zahra
    Fathi-Ashtian, Ali
    HajiFathali, Abbas
    Nasrollahi, Bita
    Ahmadi, Fazlollah
    SUPPORTIVE CARE IN CANCER, 2023, 31 (07)
  • [27] Clostridium Difficile Colonization and Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
    Bruminhent, Jackrapong
    Wang, Zi-Xuan
    Hu, Carol
    Wagner, John
    Sunday, Richard
    Bobik, Brent
    Hegarty, Sarah
    Keith, Scott
    Alpdogan, Seyfettin
    Carabasi, Matthew
    Filicko-O'Hara, Joanne
    Flomenberg, Neal
    Kasner, Margaret
    Outschoorn, Ubaldo Martinez
    Weiss, Mark
    Flomenberg, Phyllis
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1329 - 1334
  • [28] Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation
    J Wiskemann
    G Huber
    Bone Marrow Transplantation, 2008, 41 : 321 - 329
  • [29] A pediatric prognostic score for patients undergoing allogeneic hematopoietic stem cell transplantation
    Arndt, Clemens
    Beck, James F.
    Gruhn, Bernd
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 509 - 515
  • [30] Symptoms and Quality of Life in Diverse Patients Undergoing Hematopoietic Stem Cell Transplantation
    Cohen, Marlene Z.
    Rozmus, Cathy L.
    Mendoza, Tito R.
    Padhye, Nikhil S.
    Neumann, Joyce
    Gning, Ibrahima
    Aleman, Ana
    Giralt, Sergio
    Cleeland, Charles S.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2012, 44 (02) : 168 - 180